Lymphoma Research Foundation to Award Grants

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 5 No 8
Volume 5
Issue 8

LOS ANGELES, Calif--The Lym-phoma Research Foundation of America is now accepting requests for applications for medical grants for the fiscal year, July 1, 1997 to June 30, 1998.

LOS ANGELES, Calif--The Lym-phoma Research Foundation of Americais now accepting requests for applications for medical grantsfor the fiscal year, July 1, 1997 to June 30, 1998.

Awards of up to $35,000 per year for salary (including fringebenefits) are available for researchers working on studies specificto lymphoma.

Applicants must hold a PhD, an MD, or an equivalent degree. Anapplicant who holds an MD must be at least a third-year fellow.All applications must be postmarked on or before Monday, November18, 1996.

For grant applications and policies governing fellowships, pleasewrite or fax: Lymphoma Research Foundation of America, 8800 VeniceBlvd, Suite 207, Los Angeles, CA 90034. Fax: 310-204-7043. Formore information, please call 310-204-7040.

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
According to Benjamin J. Golas, MD, PIPAC could be used as a bridging therapy before surgical debulking or between subsequent large surgical operations.
1 expert is featured in this series.
2 experts are featured in this series.
2 experts are featured in this series.
5 experts are featured in this series
5 experts are featured in this series
2 experts in this video
“If you have a [patient in the] fourth or fifth line, [JNJ-5322] could be a valid drug of choice,” said Rakesh Popat, BSc, MBBS, MRCP, FRCPath, PhD.
2 experts in this video
Earlier treatment with daratumumab may be better tolerated for patients with pretreated MRD-negative multiple myeloma.
Related Content